Kathleen Borthwick
Senior VP, CFO, Principal Financial Officer & Principal Accounting OfficerMs. Kathleen Borthwick is Chief Financial Officer of Passage Bio, Inc. from March 1, 2024 and served as its Interim Chief Financial Officer since July 28, 2023 until March 1, 2024 and served as its Senior VP of Finance since July 2023 and serves as its Senior VP and serves as its Principal Financial Officer and Principal Accounting Officer since July 28, 2023. Ms. Borthwick had served as Vice President of Finance at Passage Bio, Inc. since November 2021 until July 28, 2023. From June 1997 to October 2021, she served in various leadership roles of increasing responsibility at Johnson & Johnson. During her tenure at Johnson & Johnson, she worked in Finance in support of Research & Development, Manufacturing, Business Development, Treasury and commercial operations for global Pharmaceutical and Medical Technology business segments. She earned her B. S. in Economics with concentrations in Accounting and Health Care Management at the Wharton School of University of Pennsylvania and her M.B.A. from the Tuck School of Business at Dartmouth College.
Positions
- Company NamePassage Bio, Inc.Stock CodePASGPositionSenior VP, CFO, Principal Financial Officer & Principal Accounting Officer
